Cybin to Present at the Stifel GMP 2nd Annual Future of Healthcare Conference on December 8, 2021

Rhea-AI Summary

Cybin, a biopharmaceutical company focused on developing therapeutics from psychedelics, has announced that CEO Doug Drysdale will present at the Stifel GMP 2nd Annual Future of Healthcare Conference.

The event will be held virtually on December 8, 2021, at 3:30 p.m. ET. Interested parties can register and view the presentation via webcast. Cybin aims to create innovative solutions for mental health issues by leveraging proprietary drug discovery platforms and collaborations with leading scientists.

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics^TM” is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the Stifel GMP 2^nd Annual Future of Healthcare Conference being held virtually on Wednesday, December 8, 2021.

Mr. Drysdale’s presentation will be webcast live on December 8, 2021 at 3:30 p.m. ET. To listen to the event, please click here to register and access the webcast. The archived webcast will also be available on the Company’s investor relations website on the Events & Presentations page.

About Cybin
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics^TM by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211201006121/en/

Investor & Media:

Leah Gibson

Vice President, Investor Relations

Cybin Inc.

leah@cybin.com

Source: Cybin Inc.

FAQ

When will Cybin CEO Doug Drysdale present at the Stifel GMP Conference?

Doug Drysdale will present on December 8, 2021, at 3:30 p.m. ET.

How can I watch Doug Drysdale's presentation at the Stifel GMP Conference?

You can register and watch the live presentation via webcast by visiting the company's official website.

What is Cybin's mission in the biopharmaceutical industry?

Cybin aims to create safe and effective therapeutics from psychedelics to address various mental health issues.

What markets is Cybin operational in?

Cybin operates in Canada, the United States, the United Kingdom, and Ireland.

What is the focus of Cybin's research and development?

Cybin focuses on progressing Psychedelics to Therapeutics by utilizing innovative drug discovery and delivery systems.